Reata Pharmaceuticals Inc

CIK 1358762 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Reata Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Oct 6, 202315-12G0001193125-23-252376
Sep 28, 202340000905148-23-001027
Sep 28, 2023SC 13D/A0001140361-23-045714
Sep 28, 2023SC 13D/A0001193125-23-245726
Sep 26, 202340000899243-23-019539
Sep 26, 202340000899243-23-019543
Sep 26, 202340000899243-23-019536
Sep 26, 202340000899243-23-019544
Sep 26, 202325-NSE0001354457-23-000700
Sep 26, 202340000899243-23-019532
Sep 26, 2023POSASR0001193125-23-242509
Sep 26, 2023SC 13D/A0001193125-23-242531
Sep 26, 202340000899243-23-019538
Sep 26, 202340000905148-23-001010
Sep 26, 202340000899243-23-019545
Sep 26, 2023S-8 POS0001193125-23-242487
Sep 26, 2023S-8 POS0001193125-23-242485
Sep 26, 2023S-8 POS0001193125-23-242507
Sep 26, 2023S-8 POS0001193125-23-242495
Sep 26, 2023S-8 POS0001193125-23-242478
Sep 26, 202340000899243-23-019537
Sep 26, 202340000899243-23-019541
Sep 26, 202340000899243-23-019533
Sep 26, 2023S-8 POS0001193125-23-242490
Sep 26, 202340000899243-23-019540